Bariatric surgery may reduce heart failure risk

November 14, 2016

NEW ORLEANS, Nov. 14, 2016 -- Bariatric surgery and other treatments that cause substantial weight loss can significantly reduce the risk of heart failure in obese patients, according to preliminary research presented at the American Heart Association's Scientific Sessions 2016.

Researchers compared 25,804 bariatric surgery patients in a Scandinavian obesity surgery registry to 13,701 Swedish nationwide registry patients who used an intensive structured lifestyle-modification program. Both groups had no history of heart failure before starting treatment and body mass indices greater than 30 and weighed on average 119 kilograms/262.35 pounds before treatment.

They found: The lifestyle modification program participants consumed a very low-energy diet of 500 calories a day for 3 to 10 weeks followed by 2 to 8 weeks of gradual incorporation of food, and then 9 months of a weight-maintenance regimen that included regular exercise, dietary advice and behavioral therapy. Around 20 percent of patients in the lifestyle modification program dropped out by the first year.

"Our study shows an association between obesity and heart failure and offers support for efforts to prevent and treat obesity aggressively, including the use of bariatric surgery," said Johan Sundstrom, M.D., Ph.D., senior author of the study and professor of epidemiology at Uppsala University in Sweden. "Bariatric surgery might affect the incidence of atrial fibrillation, diabetes and hypertension -- known risk factors of heart failure -- explaining the lower risk of heart failure we observed."

While the findings report that heart failure risk is lower in patients who lose more weight, it does not prove that obesity causes heart failure, he said. But, patients in both treatment groups lost weight intentionally, supporting the idea.

The study was done in a most likely white Scandinavian population. Whether the study's findings would relate to a U.S. population is unclear. In addition, because the study's participants did not have heart failure before the weight-loss treatment, "the study does not provide any advice on how to treat cardiovascular disease in obese patients," Sundstrom said.

American Heart Association, American College of Cardiology and the Obesity Society Clinical Practice guidelines advise adults with a body mass index (BMI) of 40 or higher and patients with a BMI of 35 or higher, who have two other cardiovascular risk factors such as diabetes or high blood pressure, that bariatric surgery may provide significant health benefits. The guidelines do not recommend weight loss surgery for people with a BMI under 35 and do not recommend one surgical procedure over another.
-end-
Co-authors are Gustaf Bruze, Ph.D.; Johan Ottosson, M.D., Ph.D.; Claude Marcus, M.D., Ph.D.; Ingmar Näslund, M.D., Ph.D.; and Martin Neovius, Ph.D. Author disclosures are on the abstract.

The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases, Uppsala University, Karolinska Institute, and the Swedish Research Council.

Note: Scientific presentation time is 10:45 a.m. CT on Monday, Nov. 14, in the Science and Technology Hall, Population Science Section.

Additional Resources: Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.

American Heart Association

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.